Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 10
1991 1
1992 3
1993 1
1997 5
1998 3
1999 15
2000 9
2001 6
2002 8
2003 13
2004 5
2005 10
2006 9
2007 10
2008 17
2009 9
2010 15
2011 6
2012 15
2013 8
2014 4
2015 7
2016 10
2017 8
2018 17
2019 13
2020 11
2021 9
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

252 results
Results by year
Filters applied: . Clear all
Page 1
Ablative Radioiodtherapie des Schilddrüsenkarzinoms.
Dietlein M, Drzezga A. Dietlein M, et al. Nuklearmedizin. 2018 Aug;57(4):118-123. doi: 10.3413/Nukmed-0976-18-05. Epub 2018 Aug 20. Nuklearmedizin. 2018. PMID: 30125924 German. No abstract available.
Propranolol und Morbus Parkinson.
Dietlein M, Dietlein F, Drzezga A. Dietlein M, et al. Nuklearmedizin. 2018 Feb;57(1):1-3. doi: 10.3413/Nukmed-0947-17-11. Epub 2018 Feb 21. Nuklearmedizin. 2018. PMID: 29536493 German. No abstract available.
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, Topp MS, Schäfer E, Hertenstein B, Soekler M, Vogelhuber M, Zijlstra JM, Keller UB, Krause SW, Wilhelm M, Maschmeyer G, Thiemer J, Dührsen U, Meissner J, Viardot A, Eich H, Baues C, Diehl V, Rosenwald A, von Tresckow B, Dietlein M, Borchmann P, Engert A. Fuchs M, et al. Among authors: dietlein m. J Clin Oncol. 2019 Nov 1;37(31):2835-2845. doi: 10.1200/JCO.19.00964. Epub 2019 Sep 10. J Clin Oncol. 2019. PMID: 31498753 Clinical Trial.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Borchmann P, Plütschow A, Kobe C, Greil R, Meissner J, Topp MS, Ostermann H, Dierlamm J, Mohm J, Thiemer J, Sökler M, Kerkhoff A, Ahlborn M, Halbsguth TV, Martin S, Keller U, Balabanov S, Pabst T, Vogelhuber M, Hüttmann A, Wilhelm M, Zijlstra JM, Moccia A, Kuhnert G, Bröckelmann PJ, von Tresckow B, Fuchs M, Klimm B, Rosenwald A, Eich H, Baues C, Marnitz S, Hallek M, Diehl V, Dietlein M, Engert A. Borchmann P, et al. Among authors: dietlein m. Lancet Oncol. 2021 Feb;22(2):223-234. doi: 10.1016/S1470-2045(20)30601-X. Lancet Oncol. 2021. PMID: 33539742 Clinical Trial.
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma.
Rothe A, Sasse S, Topp MS, Eichenauer DA, Hummel H, Reiners KS, Dietlein M, Kuhnert G, Kessler J, Buerkle C, Ravic M, Knackmuss S, Marschner JP, Pogge von Strandmann E, Borchmann P, Engert A. Rothe A, et al. Among authors: dietlein m. Blood. 2015 Jun 25;125(26):4024-31. doi: 10.1182/blood-2014-12-614636. Epub 2015 Apr 17. Blood. 2015. PMID: 25887777 Free PMC article. Clinical Trial.
[Hyperthyreodism for family physicians].
Zieren HU, Leu BM, Dietlein M. Zieren HU, et al. Among authors: dietlein m. MMW Fortschr Med. 2018 Oct;160(17):38-42. doi: 10.1007/s15006-018-0982-2. MMW Fortschr Med. 2018. PMID: 30302684 Review. German. No abstract available.
[Malignant goiter--thyroid cancer].
Reiners C, Dietlein M, Luster M. Reiners C, et al. Among authors: dietlein m. Dtsch Med Wochenschr. 2008 Oct;133(43):2215-28; quiz 2229-30. doi: 10.1055/s-0028-1091265. Epub 2008 Oct 15. Dtsch Med Wochenschr. 2008. PMID: 18924056 Review. German. No abstract available.
[Amiodarone-induced thyroid gland dysfunctions].
Gassanov N, Dietlein M, Caglayan E, Erdmann E, Er F. Gassanov N, et al. Among authors: dietlein m. Dtsch Med Wochenschr. 2010 Apr;135(16):807-11. doi: 10.1055/s-0030-1251935. Epub 2010 Apr 13. Dtsch Med Wochenschr. 2010. PMID: 20391312 Review. German.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann P, Goergen H, Kobe C, Lohri A, Greil R, Eichenauer DA, Zijlstra JM, Markova J, Meissner J, Feuring-Buske M, Hüttmann A, Dierlamm J, Soekler M, Beck HJ, Willenbacher W, Ludwig WD, Pabst T, Topp MS, Hitz F, Bentz M, Keller UB, Kühnhardt D, Ostermann H, Schmitz N, Hertenstein B, Aulitzky W, Maschmeyer G, Vieler T, Eich H, Baues C, Stein H, Fuchs M, Kuhnert G, Diehl V, Dietlein M, Engert A. Borchmann P, et al. Among authors: dietlein m. Lancet. 2017 Dec 23;390(10114):2790-2802. doi: 10.1016/S0140-6736(17)32134-7. Epub 2017 Oct 20. Lancet. 2017. PMID: 29061295 Clinical Trial.
252 results